NKTRNasdaq United States
Market cap
$2.584 B
$76.48 +4.13%
Close of 7 Aug 2026
Revenue
$55.2M
#2708 by revenue
Earnings
-$164.0M
Loss-making
Shares outstanding
28,687,963
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Nektar Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.